Timothy J. Harris

Partner | Palo Alto
|
(650) 813-5784
Representing Silicon Valley startups and investors for over 20 years has armed me with a wealth of expertise in the customs, practices, and issues faced in building successful businesses.

Experience

Represented the SoftBank Vision Fund and SoftBank Group Corp. in several billion dollars of portfolio investments, including investments in Katerra, DoorDash, Cohesity, View, Opendoor, Plenty, Vir Biotechnology, Clutter, Lemonade, Creditas, and Berkshire Grey.

Represented Zoox, Inc. from inception, including over $750 million in venture capital financings.

Represented Treasure Data, Inc. from inception, including over $20 million in venture capital financings and its sale to Arm Holdings US, Inc.

Represented Reflexion Medical, Inc. from inception, including over $50 million in venture capital financings.

Represented Aeva, Inc. from inception, including over $45 million in venture capital financings.

Represented Serena & Lily, Inc. in over $50 million of venture capital and private equity financings.

Represented Atheer, Inc. since inception, including in over $30 million in venture capital financings, acquisitions of OnTheGo, SpaceView, and Flype and numerous strategic commercial transactions.

Represented Artivest, Inc. in its venture capital financings and its business combination with Altegris.

Represented Fever Labs since inception, including over $75 million of venture capital financings.

Represented top tier venture capital firms in dozens of portfolio investments, including Cota Capital, Blackbird Ventures, Sutter Hill Ventures, Sequoia Capital, Trinity Ventures, Winklevoss Capital, DBL Investors, Split Rock Partners, Orbimed, Mitsui & Co. Global Investment, and Khosla Ventures.

Represented Everi (formerly known as Global Cash Access) (NYSE: EVRI), O2 Micro (Nasdaq:  OIIM), FortuNet (formerly Nasdaq:  FNET), SHFL Entertainment (formerly Nasdaq:  SHFL), and AeroCentury (NYSE American:  ACY) in their initial public offerings, United States Securities and Exchange Commission reporting, acquisitions, proxy solicitations, and going private transactions.

Legal 500 US 2009 – 2015; 2017 – 2019

Recommended for M&A/Corporate

Legal 500 US 2009 – 2015; 2017 – 2019

Recommended for Venture Capital and Emerging Companies